Boothbay Fund Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Boothbay Fund Management’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-101,000	Closed	-$9.1M	–	1831
2024 Q4	$9.1M	Buy	+101,000	New	+$9.79M	0.22%	116
2024 Q2	–	Sell	-29,700	Closed	-$2.82M	–	1891
2024 Q1	$2.82M	Buy	+29,700	New	+$2.76M	0.05%	396
2023 Q4	–	Sell	-139,800	Closed	-$10.2M	–	2044
2023 Q3	$10.2M	Buy	+139,800	New	+$11.2M	0.24%	74
2023 Q1	–	Sell	-20,200	Closed	-$1.68M	–	2538
2022 Q4	$1.68M	Sell	20,200 -6,600	-25%	-$534K	0.04%	665
2022 Q3	$2.13M	Sell	26,800 -34,900	-57%	-$2.94M	0.05%	543
2022 Q2	$4.58M	Sell	61,700 -46,500	-43%	-$3.49M	0.12%	207
2022 Q1	$9.72M	Buy	108,200 +97,800	+940%	+$9.03M	0.23%	71
2021 Q4	$1.16M	Sell	10,400 -50,700	-83%	-$6.11M	0.03%	683
2021 Q3	$7.68M	Buy	+61,100	New	+$7.87M	0.21%	89

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Boothbay Fund Management's XBI Position: Q1 2026 in Review

Boothbay Fund Management opened a new position in State Street SPDR S&P Biotech ETF (XBI) in Q1 2026: 8,924 shares worth $1.14M. The stake represents 0.01% of the portfolio and ranks #882 among its holdings. This is a return to the name: Boothbay Fund Management previously reported a position in XBI as recently as Q3 2024.

Boothbay Fund Management first reported a position in XBI in Q1 2017 and has held it in 8 quarters since. The position peaked at $1.2M in Q3 2018. 814 funds tracked by Wall St. Rank hold XBI as of Q1 2026.

Boothbay Fund Management held 8,924 shares of State Street SPDR S&P Biotech ETF worth $1.14M as of Q1 2026.
State Street SPDR S&P Biotech ETF was a new Boothbay Fund Management position in Q1 2026.
State Street SPDR S&P Biotech ETF made up 0.01% of Boothbay Fund Management's portfolio in Q1 2026, its #882 holding.
Boothbay Fund Management first reported a position in State Street SPDR S&P Biotech ETF in Q1 2017 and has held it in 8 quarters since.
Boothbay Fund Management's State Street SPDR S&P Biotech ETF position peaked at $1.2M in Q3 2018.
814 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.

Based on Boothbay Fund Management's 13F filing for Q1 2026, filed 15 May 2026.